VARIANT BIO
Variant Bio is leveraging the power of human genetic diversity to discover new therapeutics. The company's focus is to identify individuals and populations around the world who are extreme outliers for traits of medical relevance and to use innovative sequencing and analytic approaches to identify genes and pathways linked to these traits. Variant Bio was founded in 2018 and headquartered in Seattle, Washington.
VARIANT BIO
Industry:
Biotechnology Genetics Medical Therapeutics
Founded:
2018-01-01
Address:
Seattle, Washington, United States
Country:
United States
Website Url:
http://www.variantbio.com
Total Employee:
11+
Status:
Active
Total Funding:
129.7 M USD
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Euro SPF Apple Mobile Web Clips Icon Content Delivery Network LetsEncrypt SSL By Default HSTS Google Apps For Business
Similar Organizations
Beam Therapeutics
Beam Therapeutics is a biotechnology company developing precision genetic medicines through the use of base editing technology.
Translate Bio
Translate Bio is a biotechnology company that specializes in biotechnology, RNA therapeutics, and rare diseases.
Scholar Rock
Scholar Rock is a biopharmaceutical company that develops and discovers new medicines and treatments for the serious diseases.
Slingshot Biosciences
Slingshot Biosciences develops next-generation synthetic cells for diagnostics and therapeutics.
Current Advisors List
Board_member
2020-05-01
Current Employees Featured
Andrew Farnum CEO @ Variant Bio
CEO
2020-01-01
Stephane Castel Co-Founder & Chief Technology Officer @ Variant Bio
Co-Founder & Chief Technology Officer
2018-11-01
Leslie Hepner Head Of Operations @ Variant Bio
Head Of Operations
2020-01-01
Gregory Tranah VP of Medical Biology @ Variant Bio
VP of Medical Biology
Founder
Investors List
SoftBank Vision Fund
SoftBank Vision Fund investment in Series B - Variant Bio
General Catalyst
General Catalyst investment in Series B - Variant Bio
Vulcan Capital
Vulcan Capital investment in Series B - Variant Bio
Casdin Capital
Casdin Capital investment in Series A - Variant Bio
Alta Partners
Alta Partners investment in Series A - Variant Bio
Sahsen Ventures
Sahsen Ventures investment in Series A - Variant Bio
Alexandria Venture Investments
Alexandria Venture Investments investment in Series A - Variant Bio
Lux Capital
Lux Capital investment in Series A - Variant Bio
Official Site Inspections
http://www.variantbio.com Semrush global rank: 2.78 M Semrush visits lastest month: 6.15 K
Unable to get host informations!!!
More informations about "Variant Bio"
About Us - Variant Bio
A unique ethical approach. We are a mission-driven company, dedicated to strong ethics, benefit sharing, and improving health around the world. Our research model is based on respect for the people and communities we work …See details»
Team - Variant Bio
At Variant Bio our mission is to leverage the power of human genetic diversity to develop life-saving therapies. Our research model is based on respect for the people and communities …See details»
Variant Bio - Crunchbase Company Profile & Funding
Variant Bio is leveraging the power of human genetic diversity to discover new therapeutics. The company's focus is to identify individuals and populations around the world who are extreme outliers for traits of medical relevance and …See details»
Variant Bio - LinkedIn
Also, VariantBio has had a pioneering approach to share value back to patient communities for many years - I discussed this concept with co-founder and CSO Kaja Wasik in 2021 (now onto a new venture).See details»
Variant Bio Company Profile 2025: Valuation, Funding …
Variant Bio General Information Description. Developer of people-driven therapies designed to improve global health by studying genes and health-related traits. The company's therapies use sequencing technology, statistical genetics, and …See details»
Passing the Torch: From Founding CSO to the Next …
Jun 6, 2023 Variant Bio is what it is today because of Kaja. Her founding vision — including both her compelling scientific thesis and her commitment to more ethical and equitable genomic research — is the…See details»
Variant Bio - Overview, News & Similar companies - ZoomInfo
View Variant Bio (www.variantbio.com) location in New York, United States , revenue, industry and description. Find related and similar companies as well as employees by title and much …See details»
Drug Company to Share Revenues With Indigenous …
6 days ago Variant Bio, a small biotech company based in Seattle, is using genetic information from Indigenous people to develop drugs for obesity and diabetes. By Brendan Borrell When Stephane Castel first ...See details»
Variant Bio Turns Five - Medium
Aug 31, 2023 This fall will mark five years since Variant Bio began its life as a genomic drug discovery company with a paradigm-changing mission — to fairly and ethically engage historically underrepresented…See details»
Variant Bio: A New Model for Genomic Research …
Jul 22, 2020 Variant Bio’s new CEO, Andrew Farnum, in Seattle. Photo credit: Stephane Castel. In my career, I’ve worked in investment banking, as an investor, and for private foundations such as the Bill ...See details»
Variant Bio Is Rehabilitating Genetic Research’s Reputation
Jul 19, 2022 Variant Bio Is Rehabilitating Genetic Research’s Reputation. Variant Bio’s commitment to ethical research and data management ensures that its research partners and …See details»
Our Work - Variant Bio
Genetic studies are only as informative as the people in them. Variant Bio combines anthropology, epidemiology, and genetics to identify relevant groups to partner with.See details»
Variant Bio - workinbiotech.com
Variant Bio is leveraging cutting-edge genomics and computational biology to discover and develop novel therapeutics for rare diseases. Their unique approach leverages the power of …See details»
Variant Bio - Craft
Variant Bio is a biotechnology company that develops human genetic diversity therapies. It offers sequencing technology, phenotyping, and statistical genetics to identify therapeutic targets …See details»
Novo inks $50M metabolic disease pact with genomics biotech
6 days ago Looking to expand its legacy in metabolic conditions, Novo Nordisk has inked a multiyear research pact with Variant Bio to better understand the genetics underlying disease …See details»
Contact Us - Variant Bio
General inquiries: info@variantbio.com. Fellowship opportunities: fellows@variantbio.com. Partnership & collaboration opportunities: partnerships@variantbio.com. At Variant Bio our …See details»
Variant Bio, Inc. (Variant Bio, Inc.) - 药物管线_专利_临床试验_投融 …
Follow Variant Bio's news and updates at and via its blog, on X/Twitter @VariantBio, on Instagram @variant_bio, and on LinkedIn. Variant Bio Contacts Sarah LeBaron von Baeyer, Director of …See details»
Introducing Variant Bio’s Phenotyping Platform and How We
Mar 22, 2023 It seems like each day genetics research projects yield some new medical insight, yet an essential counterpart to genetic data in order to make associations is seldom discussed …See details»
Variant Bio Announces Formal Commitment to Benefit Sharing
Nov 11, 2020 Participating in a genetic study means giving away more than just a few drops of your blood or saliva. It means giving away precious genetic data — data that is potentially …See details»
Variant Bio Announces Multi-Year Research Partnership
Jan 7, 2025 Follow Variant Bio's news and updates at variantbio.com and via its blog, on X/Twitter @VariantBio, on Instagram @variant_bio, and on LinkedIn. View original content to …See details»